Cardiovascular risk

Assessing cardiovascular risk

Optimal cardiovascular risk assessment allows doctors to adjust treatment in high-risk patients at an early stage.

Improve your cardiovascular risk assessment

The extensively validated AGE Reader provides an immediate and non-invasive cardiovascular risk prediction. The AGE Reader is very easy to use measurement and leads to clinically valuable extra information.

The AGE Reader dramatically improves the cardiovascular risk prediction for diabetes, renal failure, and atherosclerosis patients. The method is convenient, easy to use and validated.

Learn more about how you can improve cardiovascular risk assessment with the AGE Reader

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced price level. The AGE Reader mu is a perfect tool for diabetologists and family doctors.
Read more »
About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.